Credit Suisse analyst Christoph Gretler raised the firm’s price target on Medacta Group to CHF 112 from CHF 105 and keeps an Outperform rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MEDGF: